Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biomed Res Int ; 2021: 2710484, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33708989

RESUMEN

Antiseptic wound ointments are widely used to treat dermal wounds that are microbially contaminated. Polygalacturonic acid (PG)+caprylic acid (CAP) is a novel combination that has been shown to eradicate biofilms. We developed a novel PG+CAP ointment and compared the biofilm eradication capability and cytotoxicity of PG+CAP with that of commercially available antiseptic wound ointments. We used a well-established biofilm model to quantitatively assess the eradication of organisms following exposure to the wound ointments for 2 hours. PG+CAP ointment completely eradicated Candida albicans, multidrug-resistant Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus biofilms, whereas MediHoney, polyhexamethylene biguanide (PHMB), and benzalkonium chloride (BZK) ointments failed to eradicate all biofilms within 2 hours. We assessed cytotoxicity by exposing L-929 fibroblasts to extracts of each ointment; Trypan blue exclusion was used to assess cell viability, and Alamar blue conversion was used to assess metabolic function. After exposure to PG+CAP and MediHoney, fibroblast viability was 96.23% and 95.23%, respectively (Trypan blue), and was comparable to untreated cells (98.77%). PHMB and BZK showed reduced viability (83.25% and 77.83%, respectively, p < 0.05). Metabolic activity results followed a similar pattern. Cytotoxicity of PG+CAP ointment towards erythrocytes was comparable to saline. PG+CAP ointment seems to be safe and can rapidly eradicate microbial biofilm; thus, PG+CAP ointment merits further in vivo testing as a potential antimicrobial wound ointment.


Asunto(s)
Biopelículas/efectos de los fármacos , Candida albicans/fisiología , Caprilatos , Staphylococcus aureus Resistente a Meticilina/fisiología , Pectinas , Pseudomonas aeruginosa/fisiología , Animales , Antiinfecciosos Locales/química , Antiinfecciosos Locales/farmacología , Biopelículas/crecimiento & desarrollo , Caprilatos/química , Caprilatos/farmacología , Línea Celular , Ratones , Pomadas , Pectinas/química , Pectinas/farmacología
2.
Artículo en Inglés | MEDLINE | ID: mdl-31932380

RESUMEN

Candida auris is an emerging pathogen that can cause virulent central-line-associated bloodstream infections. Catheter salvage through the eradication of biofilms is a desirable therapeutic option. We compared taurolidine and minocycline-EDTA-ethanol (MEE) catheter lock solutions in vitro for the eradication of biofilms of 10 C. auris strains. MEE fully eradicated all C. auris biofilms, while taurolidine lock partially eradicated all of the C. auris biofilms. The superiority was significant for all C. auris strains tested (P = 0.002).


Asunto(s)
Biopelículas/efectos de los fármacos , Candida/efectos de los fármacos , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Ácido Edético/uso terapéutico , Etanol/uso terapéutico , Minociclina/uso terapéutico , Antibacterianos/uso terapéutico , Biopelículas/crecimiento & desarrollo , Candida/crecimiento & desarrollo , Candidiasis/tratamiento farmacológico , Candidiasis/prevención & control , Infecciones Relacionadas con Catéteres/prevención & control , Catéteres Venosos Centrales/efectos adversos , Catéteres Venosos Centrales/microbiología , Humanos , Taurina/análogos & derivados , Taurina/uso terapéutico , Tiadiazinas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA